The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Podcasts
Learn about how the significant number of clinical alarms have a numbing effect on nursing staff, to the point that patient safety is in jeopardy.
Webcast
Supply chain is in the unique position, working with so many different disciplines within the hospital, that it is natural that they initiate conve
Podcasts
In this three-part webcast, Howard Mann, Vice President, Supply Chain Management at Cardiovascular Care Group discusses the basics and relationship
On-Demand Educational Webinars
A panel of health care industry leaders shares their insights and experiences in creating a best-practice supply chain that supports the intersection…
Podcasts
AHRMM Podcast on how supply chain should be interdepartmentally conversing to determine the handling of human-origin medical products and their UDIs.
Webcast
In this three-part series, Lisa Tonkinson and Chris Wiekert discuss how the Revenue Cycle can impact your supply chain when embarking on a new soft